Evidence-based labour ward guidelines for the diagnosis, management and treatment of spontaneous preterm labour

References

• Abramov Y., Nadjari M., Weinstein D., Ben-Shachar I., Plotkin V. and Ezra Y. (2000) Indomethacin for preterm labor: a randomised comparison of vaginal and rectal— oral routes. Obstetrics and Gynecology, 95, 482–486.
   PubMed Web of Science ®Google Scholar
• Aghajafari F., Murphy K., Hannah M. and Amankwah K. (2001) Repeated courses of antenatal corticosteroids: a systematic review and meta-analysis. American Journal of Obstetrics and Gynecology, 184, S36.
   Google Scholar
• Al-Qattan F., Omu A.E. and Labeeb N. (2000) A prospective randomised study comparing nifedipine versus ritodrine for the suppression of preterm labour. Medical Principles and Practice, 9, 164— 173.
   Google Scholar
• Beall M.H., Edgar B.W., Paul R.H. and Smith-Wallace T. (1985) A comparison of ritodrine, terbutaline and magnesium sulphate for the suppression of preterm labor. American Journal of Obstetrics and Gynecology, 153, 854— 859.
   Google Scholar
• Besinger R.E. and Iannucci T.A. (1997) Tocolytic therapy. In: Preterm Labour, edited by Elder M.G., Lamont R.F. and Romero R., pp. 243–297. New York, Churchill Livingstone.
   Google Scholar
• Bivins H.A., Newman R.B., Fyfe D.A., Campbell B.A. and Stramm S.L. (1993) Randomized trial of oral indomethacin and terbutaline sulfate for the long-term suppression of preterm labor. American Journal of Obstetrics and Gynecol-ogy, 169, 1065–1070.
   PubMed Web of Science ®Google Scholar
• Black R.S., Lees C., Thompson C., Pickles A. and Campbell S. (1999) Maternal and foetal cardiovascular effects of trans-dermal glyceryl trinitrate and intravenous ritodrine. Obste-trics and Gynecology, 94, 572— 576.
   Google Scholar
• Bossmar T. (1998) Treatment of preterm labour with the oxytocin and vasopressin antagonist Atosiban. Journal of Perinatal Medicine, 26, 458–465.
   PubMedGoogle Scholar
• Campbell D.M. and MacGillivray I. (1997) Maternal physio-logical responses and birthweight in singleton and twin pregnancies by parity. European Journal of Obstetrics, Gynecology, and Reproductive Biology, 7, 17— 24.
   Google Scholar
• Chau A.C., Gabert HA. and Miller J.M. (1992) A prospective comparison of terbutaline and magnesium for tocolysis. Obstetrics and Gynecology, 80, 847 — 851.
   Google Scholar
• Childress C.H. and Katz V.L. (1994) Nifedipine and its indications in obstetrics and gynecology. Obstetrics and Gynecology, 83, 616 — 624.
   Google Scholar
• Costeloe K., Hennessy E., Gibson A.T., Marlow N. and Wilkinson A.R. (2000) The EPICure study: outcomes to discharge from hospital for infants born at the threshold of viability. Pediatrics, 106, 659–671.
   PubMed Web of Science ®Google Scholar
• Crowley P. (2001) Prophylactic Corticosteroids For preterm Birth [Cochrane Review]. The Cochrane Library, Issue 4. Oxford: Update Software.
   Google Scholar
• Crowley P., Chalmers I. and Keirse M.J.N.C. (1990) The effects of corticosteroid administration before preterm delivery: an overview from the evidence from controlled trials. British Journal of Obstetrics and Gynaecology, 97, 11 —25.
   PubMedGoogle Scholar
• Crowther C.A., Hiller J.E., Doyle L.W. (2003) Magnesium Sulphate for Preventing Preterm Birth in Threatened Preterm Labour [Cochrane Review]. The Cochrane Library, Issue 2, 2003. Oxford: Update Software Ltd.
   Google Scholar
• European Atosiban Study Group (2001) The oxytocin antago-nist atosiban versus the /3-agonist terbutaline in the treatment of preterm labour. Acta Obstetrica et Gynecologica Scandi-navica, 80, 413 — 422.
   Google Scholar
• Ferguson J.E., Dyson D.C., Schutz T. and Stevenson D.K. (1990) A comparison of tocolysis with nifedipine or ritodrine: analysis of efficacy and maternal, fetal and neonatal outcome. American Journal of Obstetrics and Gynecology, 163, 105–111.
   PubMed Web of Science ®Google Scholar
• Finnström O., Otterblad Olausson P., Sedin G., Serenius F., Svenningsen N., Thiringer K., Tunell R., Wennergven M. and Wesstrom C. (1997) The Swedish national prospective study on extremely low birthweight (ELBW) infants. Incidence, mortality, morbidity and survival in relation to level of care. Acta Paediatrica, 86, 503–511.
   PubMed Web of Science ®Google Scholar
• Fisher J.E., Smith R.S., Lagrandeur R. and Lorenz R.P. (1997) Gestational diabetes mellitus in women receiving beta-adrenergics and corticosteroids for threatened preterm delivery. Obstetrics and Gynecology, 90, 880— 883.
   Google Scholar
• French/Australian Atosiban Investigators Group (2001) Treat-ment of preterm labor with the oxytocin antagonist atosiban: a double-blind, randomized, controlled comparison with salbutamol. European Journal of Obstetrics, Gynecology, and Reproductive Biology, 98, 177— 185.
   Google Scholar
• Garcia-Velasco J.A. and Gonzalez-Gonzalez A. (1998) A prospective, randomised trial of nifedipine vs ritodrine in threatened preterm labor. International Journal of Gynaecol-ogy and Obstetrics, 61, 239–244.
   PubMed Web of Science ®Google Scholar
• Gardner M.O., Owen J., Skelly S. and Hauth J.C. (1996) Preterm delivery after indomethacin: a risk factor for neonatal complications? Journal of Reproductive Medicine, 41, 903 — 906.
   Google Scholar
• Hall M.H., Danielian P. and Lamont R.F (1997) The importance of preterm birth. In: Preterm Labour, edited by Elder M.G., Lamont R.F. and Romero R., pp. 1–28. New York, Churchill Livingstone.
   Google Scholar
• Hearne A.E and Nagey D.A. (2000) Therapeutic agents in preterm labour: tocolytic agents. Clinical Obstetrics and Gynecology, 43, 787–801.
   Google Scholar
• Highby K. and Suiter C.R. (1999) A risk— benefit assessment of therapies for premature labour. Drug Safety, 21, 35–56.
   PubMedGoogle Scholar
• Hole J.W. and Tressler T.B. (2001) Management of preterm labour. Journal of American Osteopathic Association, 101, S14—S18.
   Google Scholar
• Jannet D., Abankwa A., Guyard B., Carbonne B., Marpeau L. and Milliez J. (1997) Nicardipine versus salbutamol in the treatment of premature labor. A prospective randomised study. European Journal of Obstetrics, Gynecology and Reproductive Biology, 73, 11–16.
   PubMed Web of Science ®Google Scholar
• Keirse M.J.N.C. (1995) New perspectives for the effective treatment of preterm labour. American Journal of Obstetrics and Gynaecology, 173, 618–628.
   PubMed Web of Science ®Google Scholar
• King J.F. (2001) Oral nicardipine was as efficacious as magnesium sulfate for treatment of preterm labor, with fewer side-effects. Evidence-based Obstetrics and Gynecology, 3, 71 — 72.
   Google Scholar
• King J.F., Grant A., Keirse M.J. and Chalmers I. (1998) Beta-mimetics in preterm labour: an overview of the randomised controlled trials. British Journal of Obstetrics and Gynaecol-ogy, 95, 211 — 222.
   Google Scholar
• King J.F., Flenady V.J., Papatsonis D.N.M., Dekker G.A., Carbonne B. (2003) How to interpret and utilise the Cochrane Review on calcium channel blockers for inhibiting preterm labour. Cochrane Database Systematic Reviews, Issue 2, Oxford: Update Software Ltd.
   Google Scholar
• Koks CA., Broelmann HA., de Kleine M.J. and Manger P.A. (1998) A randomized comparison of nifedipine and ritodrine for suppression of preterm labor. European Journal of Obstetrics, Gynecology and Reproductive Biology, 77, 171 — 176.
   Google Scholar
• Kupfermine M., Lessing J.B., Yaron Y. and Peyser M.R. (1993) Nifedipine versus ritodrine for suppression of preterm labour. British Journal of Obstetrics and Gynaecology, 100, 1090–1094.
   PubMedGoogle Scholar
• Lammintausta R. and Erkkola R. (1979) Effect of long term salbutamol treatment on renin aldosterone system in twin pregnancy. Acta Obstetricia et Gynaecologica Scandinavica, 58, 447 — 451.
   Google Scholar
• Lamont R.F. (2000) The pathophysiology of pulmonary oedema with the use of beta-agonists. British Journal of Obstetrics and Gynaecology, 107, 439–444.
   Google Scholar
• Lamont R.F., Dunlop P.D., Crowley P., Levene M.I. and Elder M.G. (1983) Comparative mortality and morbidity of infants transferred in utero or postnatally. Journal of Perinatal Medicine, 11, 200–203.
   PubMed Web of Science ®Google Scholar
• Lees C.C., Lojacono A., Thompson C., Danti L., Black R.S., Tanzi P., White R. and Campbell S. (1999) Glyceryl trinitrate and ritodrine in tocolysis: an international multicenter randomised study. Obstetrics and Gynecology, 94, 403 —408.
   Google Scholar
• Lockwood C.J., Senyel A.E., Dische MR., Casal D., Shah K.D., Thung S.N., Jone S., Deligdisc L. and Garite J.J. (1991) Foetal fibronectin in cervical and vaginal secretions as a predictor of preterm delivery. New England Journal of Medicine, 325, 669–674.
   PubMed Web of Science ®Google Scholar
• Lopez-Bernal A. and TambyRaja R.L. (2000) Preterm labour. Bailliere's Best Practice and Research. Clinical Obstetrics and Gynaecology, 14, 133–153.
   PubMedGoogle Scholar
• Magowan R.A., Pain M., Juszczak B.E. and McInnery K. (1999) Neonates mortality among Scottish preterm singleton births. Neonatal Intensive Care, 12, 47–50.
   Google Scholar
• Merrill J.D., Clyman R.I. and Norton M.E. (1994) Indometha-cffi as a tocolytic agent: the controversy continues. Journal of Pediatrics, 124, 734 — 736.
   Google Scholar
• Mittendorf R., Covert R., Boman J., Khoshnood B., Lee K.S. and Siegler M. (1997) Is tocolytic magnesium sulphate associated with increased total paediatric mortality? Lancet, 350, 1517— 1518.
   Google Scholar
• Morales W.J. and Madhav H. (1993) Efficacy and safety of indomethacin compared with magnesium sulphate in the management of preterm labour: a randomized study. Amer-ican Journal of Obstetrics and Gynecology, 169, 97–102.
   PubMed Web of Science ®Google Scholar
• Moutquin J.M., Sherman D., Cohen H., Mohide PT., Hochner-Celnikier D., Fejgin M., Liston R.M., Dansgreau J., Mazor M., Shalev E., Boucher M., Glezerman M., Zimmer E. and Rabinovici I.N. (2000) Double-blind, randomized, controlled trial of atosiban and ritodrine in the treatment of preterm labour: a multicenter effectiveness and safety study. American Journal of Obstetrics and Gynecology, 182, 1191–1199.
   PubMed Web of Science ®Google Scholar
• National Institutes of Health Consensus Development Panel (2001) Antenatal corticosteroids revisited; repeat courses. Obstetrics and Gynecology, 98, 144 — 150.
   Google Scholar
• National Institutes of Health Consensus Statement (1994) Effect of Corticosteroids for Foetal Maturation on Perinatal Outcome, Vol. 12, No. 2: 28 February —2 March.
   Google Scholar
• Papatsonis D.N., Van-Geijn H.P., Ader H.J., Lange F.M., Bleker O.P. and Dekker G.A. (1997) Nifedipine and ritodrine in the management of preterm labor: a randomised multi-center trial. Obstetrics and Gynecology, 90, 230— 234.
   Google Scholar
• Papatsonis D.N.M., Kok J.H., Van-Geijn H.P., Bleker O.P., Ader H.J. and Dekker G.A. (2000) Neonatal effects of nifedipine and ritodrine for preterm labor. Obstetrics and Gynecology, 95, 477 — 481.
   Google Scholar
• Papatsonis D.N.M., Lok CAR., Bos J.M., Geijn H.P. and Dekker G.A. (2001) Calcium channel blockers in the management of preterm labour and hypertension in preg-nancy. European Journal of Obstetrics, Gynecology, and Reproductive Biology, 97, 122 — 140.
   Google Scholar
• Romero R., Sibai B.M., Sanchez-Ramos L., Valenzuela G.J., Veille J., Tabor B., Perry K.J., Varner M., Goodwin TM., Lane R., Smith J., Shangold G. and Creasy G.W. (2000) An oxytocin receptor antagonist (atosiban) in the treatment of preterm labour: a randomized, double-blind, placebo-con-trolled trial with tocolytic rescue. American Journal of Obstetrics and Gynecology, 182, 1173–1183.
   PubMed Web of Science ®Google Scholar
• Royal College of Obstetricians and Gynaecologists (1997) Beta-agonists for the care of women in preterm labour. Guideline 1A, January. London, RCOG Press.
   Google Scholar
• Rozenberg P. (2001) Tocolysis, use of beta-sympathomimetics for threatening preterm delivery: a critical review. Journal de Gynécologie Obstétrique et Biologie de la Reproduction (Paris), 30, 221–230.
   PubMedGoogle Scholar
• Rozenberg P., Goffinet F. and Hessabi M. (1999) Comparison of the Bishop score, of sonographic measurement of the cervical length and fibronectin determination in predicting time to delivery and the type of delivery at term. Bulletin de l'Academie Nationale de Medecine, 183, 589–599.
   PubMedGoogle Scholar
• Rozenberg P., Goffinet F., Malagrida L., Giudicelli Y., Perdu M., Houssin I. et al. (1997) Evaluating the risk of preterm delivery: a comparison of foetal fibronectin and transvaginal ultrasonographic measurement of cervical length. American Journal of Obstetrics and Gynecology, 176, 196 — 199.
   Google Scholar
• Schmitz T., Goffinet F., Jarreau PH., Moriette G. and Cabrol D. (2000) Repetition of corticoid treatment for foetal lung maturation: clinical and experimental scientific data. Journal de Gynécologie Obstétrique et Biologie de la Reproduction (Paris), 29, 458–468.
   PubMedGoogle Scholar
• Schorr S.J., Ascarelli M.H., Rust O.A., Ross EL., Calfee EL., Perry K.G. and Morrison J.C. (1998) A comparative study of ketorolac (Toradol) and magnesium sulfate for arrest of preterm labor. Southern Medical Journal, 91, 1028–1032.
   PubMedGoogle Scholar
• Scudiero R., Khoshnood B., Pryde PG., Lee KS., Wall S. and Mittendorf R. (2000) Perinatal death and tocolytic magne-sium sulphate. Obstetrics and Gynecology, 96, 178–182.
   PubMed Web of Science ®Google Scholar
• Sibony O., de Gayffier A. and Carbillon L, (1994) Has the use of indomethacin during pregnancy consequences newborn infants? Prospective study of 83 pregnant women and 115 newborn infants. Archives de Pediatrie, 1, 709–715.
   PubMedGoogle Scholar
• Spisso KR., Harbert G.M. Jr and Thiagarajah S. (1982) The use of magnesium sulfate as the primary tocolytic agent to prevent premature delivery. American Journal of Obstetrics and Gynecology, 142, 840— 845.
   Google Scholar
• Tsatsaris V., Carbonne B. (2001) Tocolysis with calcium channel blockers. Journal de Gynécologie Obstétrique et Biologie de la Reproduction (Paris), 30, 246–251.
   PubMedGoogle Scholar
• Vause S. and Johnston T. (2000) Management of preterm labour. Archives of Disease in Childhood, Fetal and Neonatal Edition, 83, F79 —F85.
   Google Scholar
• Vermillion ST., Soper D.E. and Newman R.B. (2000) Neonatal sepsis and death after multiple courses of antenatal betamethasone therapy. American Journal of Obstetrics and Gynecology, 183, 810–814.
   PubMedGoogle Scholar
• Wood N.S., Marlow M., Costeloe K., Gibson A.T. and Wilkinson A.R. (2000) Neurologic and developmental dis-ability after extremely preterm birth. New England Journal of Medicine, 343, 378–384.
   Google Scholar
• Woolf S.H., Grol R., Hutchinson A., Eccles M.P. and Grimshaw J.M. (1999) The potential benefits, limitations and harms of clinical guidelines. British Medical Journal, 318, 527–530.
   PubMed Web of Science ®Google Scholar
• World Health Organization (1993) International Statistical Classification of Diseases and Related Health Problems, 10th revision, Vol. 2. Geneva, Switzerland: WHO.
   Google Scholar
• Worldwide Atosiban versus Beta-agonists Study Group (2001) Effectiveness and safety of the oxytocin antagonist atosiban versus beta-adrenergic agonists in the treatment of preterm labour. British Journal of Obstetrics and Gynaecology, 108, 133–142.
   Google Scholar